{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:28:15Z","timestamp":1793316495717,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.neuropharm.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T21:15:58Z","timestamp":1377119758000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"special_numbering":"PA","title":["Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease"],"prefix":"10.1016","volume":"76","author":[{"given":"Paula L.","family":"McClean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.08.005_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2009.06.035","article-title":"Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer's disease","volume":"205","author":"Abbas","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib3","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1523\/JNEUROSCI.22-02-00515.2002","article-title":"Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice","volume":"22","author":"Bondolfi","year":"2002","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nature Neuroscience"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2013.08.005_bib7","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1038\/sj.bjp.0707509","article-title":"Role of the brain-derived neurotrophic factor at glutamatergic synapses","volume":"153","author":"Carvalho","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0304-3940(96)13149-9","article-title":"Synaptic release rather than failure in the conditioning pulse results in paired-pulse facilitation during minimal synaptic stimulation in the rat hippocampal CA1 neurones","volume":"218","author":"Chen","year":"1996","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/378192a0","article-title":"Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in\u00a0vivo","volume":"378","author":"Cohen-Cory","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D'Hooge","year":"2001","journal-title":"Brain Research. Brain Research Reviews"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib12","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","article-title":"Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease","volume":"4","author":"Deane","year":"2007","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST20051101","article-title":"Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib18","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1523\/JNEUROSCI.21-13-04691.2001","article-title":"Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein","volume":"21","author":"Fitzjohn","year":"2001","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib20","doi-asserted-by":"crossref","first-page":"e9764","DOI":"10.1371\/journal.pone.0009764","article-title":"Synaptic plasticity in the hippocampus of a APP\/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice","volume":"5","author":"Gengler","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","article-title":"Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice","volume":"33","author":"Gengler","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/156720506775697106","article-title":"Neurodegeneration and neurogenesis: focus on Alzheimer's disease","volume":"3","author":"Greenberg","year":"2006","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST0390891","article-title":"Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease","volume":"39","author":"Holscher","year":"2011","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/REVNEURO.2005.16.3.181","article-title":"Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies","volume":"16","author":"H\u00f6lscher","year":"2005","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib27","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","article-title":"Central nervous system effects of intranasally administered insulin during euglycemia in men","volume":"48","author":"Kern","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib30","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/77046","article-title":"Gene-expression profile of the ageing brain in mice","volume":"25","author":"Lee","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib34","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama Study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib36","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","article-title":"Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells","volume":"14","author":"Paresce","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2002-4605","article-title":"The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease","volume":"4","author":"Perry","year":"2002","journal-title":"Journal of Alzheimer's Disease: JAD"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"Perry","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.10611","article-title":"Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron","volume":"72","author":"Perry","year":"2003","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"A\u00df42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Reports"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0928-4257(96)80546-8","article-title":"Using paired-pulse facilitation to probe the mechanisms for long-term potentiation","volume":"89","author":"Schulz","year":"1995","journal-title":"Journal of Physiology (Paris)"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib45","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eplepsyres.2008.02.001","article-title":"Seizures induced by GABAB-receptor blockade in early-life induced long-term GABA(B) receptor hypofunction and kindling facilitation","volume":"79","author":"Tsai","year":"2008","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nprot.2006.277","article-title":"Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain","volume":"1","author":"Wilcock","year":"2006","journal-title":"Nature Protocols"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-84","article-title":"Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies","volume":"11","author":"Wohlfart","year":"2013","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib49","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1523\/JNEUROSCI.22-05-01532.2002","article-title":"Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis","volume":"22","author":"Ying","year":"2002","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2004.02.045","article-title":"Insulin and the insulin receptor in experimental models of learning and memory","volume":"490","author":"Zhao","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.neuropharm.2013.08.005_bib52","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}","volume":"284","author":"Zhao","year":"2009","journal-title":"The Journal of Biological Chemistry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813003626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813003626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T09:01:55Z","timestamp":1646384515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813003626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":52,"alternative-id":["S0028390813003626"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}